Table 4.

Geometric Mean Cardiometabolic Outcomes at Baseline and Relative Changes During Diet Phases

	Baseline	DASH1 v Baseline	WFPB v Baseline	DASH2 v Baseline	WFPB v DASH1	WFPB v DASH2	DASH2 v DASH1
Total Cholesterol, mg/dL	156 (138, 176)	0.96 (0.9, 1.02)	0.82 (0.77, 0.88)	0.9 (0.84, 0.96)	0.86 (0.81, 0.92)	0.91 (0.86, 0.97)	0.94 (0.88, 1)
Triglycerides, mg/dL	124 (98, 158)	1.04 (0.94, 1.15)	0.98 (0.88, 1.09)	0.97 (0.87, 1.08)	0.94 (0.85, 1.04)	1.01 (0.91, 1.12)	0.93 (0.84, 1.04)
HDL Cholesterol, mg/dL	43 (37, 50)	0.98 (0.92, 1.03)	0.92 (0.87, 0.98)	0.94 (0.88, 1)	0.95 (0.89, 1)	0.98 (0.93, 1.04)	0.96 (0.91, 1.02)
LDL Cholesterol, mg/dL	82 (64, 105)	0.89 (0.79, 1.01)	0.69 (0.61, 0.78)	0.86 (0.75, 0.97)	0.78 (0.69, 0.88)	0.81 (0.71, 0.92)	0.96 (0.85, 1.09)
Weight, kg	95.3 (85.5, 106.2)	0.98 (0.98, 0.99)	0.97 (0.97, 0.98)	0.97 (0.96, 0.98)	0.99 (0.98, 1)	1 (1, 1.01)	0.99 (0.98, 0.99)
Systolic BP, mmHg	130 (124, 137)	0.99 (0.96, 1.02)	0.98 (0.95, 1.01)	0.96 (0.92, 0.99)	0.99 (0.96, 1.03)	1.03 (0.99, 1.06)	0.97 (0.94, 1)
Diastolic BP, mmHg	69 (64, 74)	1.03 (0.97, 1.1)	0.96 (0.9, 1.03)	0.97 (0.91, 1.04)	0.94 (0.88, 1)	0.99 (0.93, 1.06)	0.95 (0.89, 1.01)
hsCRP, mg/L	2.3 (1.3,4.1)	0.84 (0.56, 1.26)	0.58 (0.38, 0.88)	0.85 (0.55, 1.3)	0.69 (0.45, 1.05)	0.68 (0.44, 1.05)	1.01 (0.66, 1.55)
Adiponectin, ng/mL	3014 (2345, 3870)	0.99 (0.8, 1.23)	0.92 (0.74, 1.14)	1.08 (0.86, 1.35)	0.93 (0.75, 1.15)	0.85 (0.68, 1.06)	1.09 (0.87, 1.36)
Leptin, ng/mL	33 (18, 62)	0.77 (0.58, 1.01)	0.72 (0.55, 0.96)	0.87 (0.66, 1.17)	0.94 (0.72, 1.24)	0.83 (0.62, 1.1)	1.14 (0.86, 1.51)

p<0.05 shown in bold. Numbers in parentheses are 95% confidence intervals.